Global Head and Neck Cancer Diagnostics Market: Trend Analysis and Forecast to 2022


Select Your License Type


samplerequest
makeanenquiry
download
Discount



                                               

                                         Figure : Global Head and Neck Cancer Diagnostics Market by region


In, size of the Global Head and Neck Cancer Diagnostics Market was valued nearly USD 500 million. The global head and neck cancer diagnostics market is projected to grow with a CAGR between 13% and 14% during 2016-2022 and reach USD 1.xx billion by 2022. Increasing geriatric patient population especially patients suffering from head and neck cancer, advancement in treatment modes, and advanced diagnostic technologies are considered as the prime factors driving the growth of this market. Moreover, unfavorable government regulations regarding new researches, high cost associated with the treatment modes and lack of awareness among the people about the head and neck cancer are the key restraining factors in this market. Furthermore, rise in the chronic diseases among aging population, rise in the healthcare expenditure of people, and better healthcare initiatives from Government and private organizations are anticipated to create more opportunities for the growth of this market during the forecast period. Nevertheless, low adoption rate of digital technology based systems and untapped markets are considered to be the challenges faced by the global head and neck cancer diagnostics market.

Segments Covered:

The global head and neck cancer diagnostics market based on diagnostic methods is segmented into diagnostic imaging, endoscopy screening, bioscopy screening, blood test and dental diagnostic and others.

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America is accounted for the largest market share region in the global head and neck cancer diagnostic market owing more than 47% share. Rising aging population with chronic disease, with head and neck cancer related and highly developed healthcare infrastructure are considered to be the key factors for the growth of this market region. Moreover, Asia pacific is expected to be the most prominent and faster growing market due to presence of emerging economies such as India, China, and Indonesia. Asia Pacific is anticipated to grow at the highest CAGR rate over the forecast period and provides more opportunities due to increasing demand for developed healthcare infrastructure, rising expenditure of patient population and rising cases of head and neck cancer in the region.

Companies Profiled:

The companies covered in the report include

  • Siemens Healthcare
  • Identafi
  • GE Healthcare
  • Philips Healthcare
  • AdDent Inc.
  • Varian Medical Systems
  • NeuSoft
  • Toshiba
  • Fujifilm Holdings
  • Hitachi Medical
  • LED Medical Diagnostics
  • BrainLab
  • Carestream
  • Xoran
  • Shimadzu Corp.
  • MinXray
  • Neurologica
  • Aribex
  • ASAHI Roentgen
  • Hologic
  • Karl Storz
  • Mediso
  • Accuray

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of head and neck cancer diagnostics globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.  The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of head and neck cancer diagnostics market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the head and neck cancer diagnostics market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

The report also provides in depth analysis of regulatory framework pertaining to  Head and Neck Cancer Diagnostic Market. This will help the companies to understand the regulatory compliances, supports, barriers in the  Head and Neck Cancer Diagnostics market.  This section highlights key amendments and their implication on  Head and Neck Cancer Diagnostics market in the short run as well as in the long run.

1.    Report Overview

1.1    Report Description
1.2    Research Methods
1.3    Research Approaches

2.    Executive Summary

3.    Head and Neck Cancer Diagnostics Market Overview

3.1    Introduction
3.2    Market Dynamics
3.3    Drivers
3.4    Restraints
3.5    Opportunities
3.6    Challenges
3.7    Porter’s Five Forces Analysis
3.8    IGR – Growth Matrix Analysis
3.9    Competitive Landscape in the Head and Neck Cancer Diagnostics Market
3.10  Regulatory Framework analysis by region

3.10.1: North America
3.10.2 Europe
3.10.3 RoW (Including APAC, and LATAM)

4. Global Head and Neck Cancer Diagnostics Market, by Diagnostic Methods, (USD Million) 2015 – 2022

4.1    Introduction
4.2    Diagnostic Imaging
4.3    Endoscopy Screening
4.4    Bioscopy Screening
4.5    Blood Tests
4.6    Dental Diagnostic
4.7    Others

5.    Global Head and Neck Cancer Diagnostic Market, by Region, (USD Million) 2015 – 2022

5.1    Introduction
5.2    North America

5.2.1    North America Head and Neck Cancer Diagnostics Market, by Diagnostic Methods (USD Million)
5.2.2    North America Head and Neck Cancer Diagnostics Market, by country (USD Million

5.3    Europe

5.3.1    Europe Head and Neck Cancer Diagnostics Market, by Diagnostic Methods (USD Million)
5.3.2    Europe Head and Neck Cancer Diagnostics Market, by country (USD Million)

5.4    Asia Pacific

5.4.1    Asia Pacific Head and Neck Cancer Diagnostics Market, by Diagnostic Methods (USD Million)
5.4.2    Asia Pacific Head and Neck Cancer Diagnostics Market, by country (USD Million)

5.5    Latin America

5.5.1    Latin America Head and Neck Cancer Diagnostics Market, by Diagnostic Methods (USD Million)
5.5.2    Latin America Head and Neck Cancer Diagnostics Market, by country (USD Million)

5.6    Rest of the World

5.6.1    RoW Head and Neck Cancer Diagnostics Market, by Diagnostic Methods (USD Million)
5.6.2    RoW Head and Neck Cancer Diagnostics Market, by country (USD Million)

6.    Company Profiles

6.1    Company Profiles
6.2    Siemens Healthcare
6.3    Identafi
6.4    GE Healthcare
6.5    Philips Healthcare
6.6    AdDent, Inc.
6.7    Varian Medical Systems
6.8    NeuSoft
6.9    Toshiba
6.10   Fujifilm Holdings
6.11   Hitachi Medical
6.12   LED Medical Diagnostics
6.13   BrainLab
6.14   Carestream
6.15   Xoran
6.16   Shimadzu Corp.
6.17   MinXray
6.18   Neurologica
6.19   Aribex
6.20   ASAHI Roentgen
6.21   Hologic
6.22   Karl Storz
6.23   Mediso
6.24   Accuray.


Got a Question?

If you have a question to ask our analyst, just fill this form and send it across, our representative will get in touch with you shortly.